Bryan Mackowiak
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Alcohol Consumption and Health Effects 11
- Co-authors
- Bin Gao (17 shared papers)Yong He (6 shared papers)Xiaolin Wang (1 shared paper)Yaojie Fu (10 shared papers)Hongbing Wang (1 shared paper)Luca Maccioni (1 shared paper)Hongbing Wang (6 shared papers)Jessica N. Hodge (1 shared paper)
- Journals
- Gut (3 papers)Molecular Pharmacology (2 papers)Biochemical Pharmacology (2 papers)Cellular and Molecular Gastroenterology and Hepatology (2 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Bryan Mackowiak
27 papers receiving 1.1k citations
Bryan Mackowiak's Hit Papers
Peers
Comparison fields: 5 of 96
- Pharmacology 206
- Cancer Research 273
- Hepatology 135
- Pathology and Forensic Medicine 227
- Biochemistry 79
Countries citing papers authored by Bryan Mackowiak
This map shows the geographic impact of Bryan Mackowiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Mackowiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Mackowiak more than expected).
Fields of papers citing papers by Bryan Mackowiak
This network shows the impact of papers produced by Bryan Mackowiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Mackowiak. The network helps show where Bryan Mackowiak may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Mackowiak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases Hit paper breakdown → | 2020 | 330 |
| 2 | Alcohol-associated liver disease Hit paper breakdown → | 2024 | 157 |
| 3 | 2018 | 96 | |
| 4 | 2016 | 92 | |
| 5 | 2022 | 48 | |
| 6 | 2015 | 47 | |
| 7 | 2023 | 46 | |
| 8 | 2021 | 34 | |
| 9 | 2024 | 29 | |
| 10 | 2019 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2021 | 28 | |
| 13 | 2022 | 20 | |
| 14 | 2019 | 17 | |
| 15 | 2023 | 15 | |
| 16 | 2019 | 11 | |
| 17 | 2017 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 6 |
About Bryan Mackowiak
Bryan Mackowiak is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Epidemiology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alcohol Consumption and Health Effects (11 papers), Pharmacogenetics and Drug Metabolism (9 papers), Liver Disease Diagnosis and Treatment (9 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Hormonal Regulation and Hypertension (6 papers), Estrogen and related hormone effects (3 papers), MicroRNA in disease regulation (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Pharmacology (206 citations), Cancer Research (273 citations), Hepatology (135 citations), Pathology and Forensic Medicine (227 citations) and Biochemistry (79 citations). Bryan Mackowiak has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Bin Gao, Yong He, Xiaolin Wang, Yaojie Fu, Hongbing Wang, Luca Maccioni, Hongbing Wang, Jessica N. Hodge, Dechun Feng and Linhao Li. Their work appears in journals such as Gut, Molecular Pharmacology, Biochemical Pharmacology, Cellular and Molecular Gastroenterology and Hepatology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.